ADEF
Adams Diversified Equity Fund Portfolio holdings
AUM
$2.79B
1-Year Return
26.53%
This Quarter Return
+9.67%
1 Year Return
+26.53%
3 Year Return
+123.11%
5 Year Return
+224.03%
10 Year Return
+556.18%
AUM
$2.02B
AUM Growth
+$138M
(+7.3%)
Cap. Flow
-$8.86M
Cap. Flow
% of AUM
-0.44%
Top 10 Holdings %
Top 10 Hldgs %
27.85%
Holding
243
New
32
Increased
16
Reduced
113
Closed
32
Top Buys
| 1 |
Medtronic
MDT
|
$24.9M |
| 2 |
NVIDIA
NVDA
|
$23.5M |
| 3 |
Mondelez International
MDLZ
|
$19.9M |
| 4 |
Johnson & Johnson
JNJ
|
$19M |
| 5 |
Netflix
NFLX
|
$18.9M |
Top Sells
| 1 |
AbbVie
ABBV
|
$24.6M |
| 2 |
Broadcom
AVGO
|
$22.6M |
| 3 |
Philip Morris
PM
|
$19.8M |
| 4 |
Labcorp
LH
|
$19.3M |
| 5 |
Halliburton
HAL
|
$16M |
Sector Composition
| 1 | Financials | 17.49% |
| 2 | Technology | 16.33% |
| 3 | Healthcare | 15.08% |
| 4 | Consumer Discretionary | 10.85% |
| 5 | Industrials | 10.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
MRC Global
MRC
$1.29B
| $484K | 0.02% |
25,800
-1,900
| -7% | -$35.6K |
|
202
Cirrus Logic
CRUS
$5.92B
| $479K | 0.02% |
12,400
-800
| -6% | -$30.9K |
|
|
LCI
203
DELISTED
Lannett Company, Inc.
LCI
| $469K | 0.02% |
24,675
+17,625
| +250% | +$335K |
|
204
Phibro Animal Health
PAHC
$1.58B
| $438K | 0.02% |
10,200
-800
| -7% | -$34.4K |
|
205
Enanta Pharmaceuticals
ENTA
$190M
| $436K | 0.02% |
5,100
-300
| -6% | -$25.6K |
|
206
Amkor Technology
AMKR
$6B
| $430K | 0.02% |
58,200
-4,100
| -7% | -$30.3K |
|
|
TVRD
207
Tvardi Therapeutics, Inc. Common Stock
TVRD
$285M
| $410K | 0.02% |
+475
| New | +$410K |
|
|
AMAG
208
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $370K | 0.02% |
18,500
-1,300
| -7% | -$26K |
|
209
MKS Inc. Common Stock
MKSI
$6.83B
| $345K | 0.02% |
4,300
-300
| -7% | -$24.1K |
|
210
Advanced Energy
AEIS
$5.66B
| $341K | 0.02% |
6,600
-500
| -7% | -$25.8K |
|
211
KLX Energy Services
KLXE
$34.8M
| $142K | 0.01% |
+888
| New | +$142K |
|
|
212
AbbVie
ABBV
$376B
| – | – |
-265,700
| Closed | -$24.6M |
|
213
AMN Healthcare
AMN
$775M
| – | – |
-15,500
| Closed | -$908K |
|
|
214
Broadcom
AVGO
$1.44T
| – | – |
-931,000
| Closed | -$22.6M |
|
215
Benchmark Electronics
BHE
$1.45B
| – | – |
-23,400
| Closed | -$682K |
|
216
Cathay General Bancorp
CATY
$3.48B
| – | – |
-19,300
| Closed | -$781K |
|
217
CytomX Therapeutics
CTMX
$346M
| – | – |
-17,800
| Closed | -$407K |
|
218
CVS Health
CVS
$93.5B
| – | – |
-174,800
| Closed | -$11.2M |
|
219
Delek US
DK
$1.92B
| – | – |
-13,000
| Closed | -$652K |
|
220
Deluxe
DLX
$871M
| – | – |
-8,800
| Closed | -$583K |
|
221
Editas Medicine
EDIT
$227M
| – | – |
-16,000
| Closed | -$573K |
|
222
Freeport-McMoran
FCX
$66.1B
| – | – |
-414,700
| Closed | -$7.16M |
|
|
223
Halliburton
HAL
$19.2B
| – | – |
-354,400
| Closed | -$16M |
|
|
224
Labcorp
LH
$22.9B
| – | – |
-125,363
| Closed | -$19.3M |
|
225
Lam Research
LRCX
$127B
| – | – |
-394,000
| Closed | -$6.81M |
|